Answers are grounded in this paper and cite their sources.
BACKGROUND Cognitive impairment‐related diseases represent a growing global health challenge, especially in elderly populations. Sweet tea ( Lithocarpus litseifolius ) is a functional food rich in neuroprotective dihydrochalcones (DST, including trilobatin, phloretin and phlorizin). However, its systematic preclinical evidence and optimal consumption dosage against cognitive impairment are still lacking. The present study aimed to investigate the neuroprotective efficacy and underlying mechanisms of DST using systematic review, meta‐analysis, dose–response evaluation and machine learning. Four databases were searched up to November 2025 and 27 preclinical studies were included. RESULTS DST significantly improved cognitive and behavioral impairments in animal models. Mechanistically, DST exerted neuroprotection by enhancing antioxidant status, alleviating neuroinflammation, regulating cholinergic function and upregulating brain‐derived neurotrophic factor expression. A non‐linear dose–response relationship was observed, with better efficacy at low‐to‐moderate doses. Machine learning modelling further characterized a robust effective preclinical dosage window of 10–20 mg kg day −1 in rodent models. CONCLUSION These dosage findings represent model‐derived estimates rather than validated optimal regimens, requiring independent experimental validation prior to clinical translation. These findings confirm the multi‐target neuroprotective effects of DST, supporting its further development as a promising functional food ingredient candidate for cognitive impairment intervention.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: